Clinical Trials Directory

Trials / Completed

CompletedNCT05177120

Central Sensitization in Familial Mediterranean Fever (FMF)

Central Sensitization in Familial Mediterranean Fever: A Cross-Sectional Observational Study

Status
Completed
Phase
Study type
Observational
Enrollment
100 (actual)
Sponsor
Marmara University · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Familial Mediterranean Fever (FMF) is an autosomal recessive inherited disease with a course of autoinflammation, which is characterized by the episodes of fever and serositis. Central sensitization (CS) is defined as increased response to normal or sub-threshold stimuli of central nervous system and its close relationship with many rheumatological diseases has been demonstrated in several studies. However, there are no data on the frequency of CS in FMF patients.

Detailed description

Familial Mediterranean fever (FMF) is a self-limiting autoinflammatory disease with well-defined genetic and clinical features. Recurrent episodes of fever and serositis accompanied by increased acute phase reactants and good response to colchicine are the core components of the disease. The frequency of this disease, which is common in Eastern Mediterranean countries, is variable according to regions, but it is reported as 1/1000. In the pathogenesis of the disease, the mutation of the MEFV (Mediterranean Fever) gene, which is located on the 16th chromosome and encodes the pyrin protein, is known as the basic mechanism.In rheumatic diseases, inflammatory mediators cause CS by first creating changes in the regulation of pain in peripheral neurons and then in spinal and supraspinal pathways. Stimulation of peripheral nerves by mediators released during inflammation results in neurogenic inflammation, which is among the peripheral sensitization (PS) mechanisms. PS is defined as the increased sensitivity of nociceptive neurons to normal or below-threshold stimuli and constitutes the first step in the development of CS.Similar to other autoimmune diseases, it is possible that the neuroinflammatory process triggers peripheral and central sensitization mechanisms in FMF patients and affects pain pathways.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTCentral Sensitization InventoryStandardized questionnaire to determine the level of central sensitization
OTHERShort form-36Standardized questionnaire to investigate the quality of life in patients
OTHERPittsburgh Sleep Quality IndexStandardized questionnaire to investigate the sleep quality and disturbance
OTHERHealth assessment questionnaireStandardized questionnaire used to detect the presence of disability
OTHERHospital anxiety and depression scaleStandardized questionnaire to investigate the depression and anxiety
DIAGNOSTIC_TESTFibromyalgia rapid screening toolStandardized questionnaire to determine the presence of fibromyalgia
OTHERFamilial Mediterranean Fever Quality of life scaleStandardized questionnaire to investigate the quality of life in Familial Mediterranean Fever patients

Timeline

Start date
2021-06-01
Primary completion
2022-04-10
Completion
2022-08-03
First posted
2022-01-04
Last updated
2022-11-10

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT05177120. Inclusion in this directory is not an endorsement.